↓ Skip to main content

Efficacy and Safety of Atezolizumab and Bevacizumab in Appendiceal Adenocarcinoma

Overview of attention for article published in Cancer Research Communications, May 2024
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter
18 X users

Readers on

mendeley
1 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Efficacy and Safety of Atezolizumab and Bevacizumab in Appendiceal Adenocarcinoma
Published in
Cancer Research Communications, May 2024
DOI 10.1158/2767-9764.crc-24-0019
Pubmed ID
Authors

Nicholas J. Hornstein, Mohammad A. Zeineddine, Betul B. Gunes, Andrew J. Pellatt, Mark Knafl, Haifeng Zhu, Anneleis F. Willett, Abdelrahman Yousef, Suyu Liu, Ryan Sun, Andrew Futreal, Scott E. Woodman, Melissa W. Taggart, Michael J. Overman, Daniel M. Halperin, Kanwal P. Raghav, John Paul Shen

X Demographics

X Demographics

The data shown below were collected from the profiles of 18 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 May 2024.
All research outputs
#3,395,750
of 26,208,484 outputs
Outputs from Cancer Research Communications
#79
of 478 outputs
Outputs of similar age
#32,681
of 253,769 outputs
Outputs of similar age from Cancer Research Communications
#10
of 43 outputs
Altmetric has tracked 26,208,484 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 478 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.4. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 253,769 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 43 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.